Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Binghao Li

Showing results (41-50 of 66) with videos related to

Pageof 7
Sort By:
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 26, 2019
Dual blockade of CXCL12-CXCR4 and PD-1-PD-L1 pathways prolongs survival of ovarian tumor-bearing mice by prevention of immunosuppression in the tumor microenvironmentYang Zeng, Binghao Li, Yingying Liang, et al.
Cancer Management and Research|May 26, 2018
Prognostic factors for survival among patients with primary bone sarcomas of small bonesZhan Wang, Shu Li, Yong Li, et al.
Bioactive Materials|December 18, 2020
A trilogy antimicrobial strategy for multiple infections of orthopedic implants throughout their life cycleYikai Wang, Wangsiyuan Teng, Zengjie Zhang, et al.
Ebiomedicine|July 21, 2018
Survival Prediction in High-grade Osteosarcoma Using Radiomics of Diagnostic Computed TomographyYan Wu, Lei Xu, Pengfei Yang, et al.
Frontiers in Oncology|October 4, 2021
Clinical Features and Serological Markers Risk Model Predicts Overall Survival in Patients Undergoing Breast Cancer and Bone Metastasis SurgeriesHaochen Mou, Zhan Wang, Wenkan Zhang, et al.
Med (New York, N.Y.)|August 29, 2025
Anti-PD-1 antibody plus anlotinib vs. anlotinib alone in patients with refractory chondrosarcoma: A multicenter, non-randomized phase 2 FLAIL-C trialBinghao Li, Lu Xie, Junbo Liang, et al.
Nature Communications|October 23, 2022
Metabolic control of CD47 expression through LAT2-mediated amino acid uptake promotes tumor immune evasionZenan Wang, Binghao Li, Shan Li, et al.
NPJ Precision Oncology|September 11, 2021
Genomic characterization and outcome evaluation of kinome fusions in lung cancer revealed novel druggable fusionsBinghao Li, Hao Qu, Jing Zhang, et al.
Frontiers in Oncology|November 1, 2021
Predictive and Prognostic Biomarkers for Lung Cancer Bone Metastasis and Their Therapeutic ValueXupeng Chai, Eloy Yinwang, Zenan Wang, et al.
Frontiers in Immunology|March 11, 2024
Multiple influence of immune cells in the bone metastatic cancer microenvironment on tumorsShixin Chen, Jiangchu Lei, Haochen Mou, et al.
Pageof 7

Showing results (41-50 of 66) with videos related to

Sort By:
Pageof 7
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 26, 2019
Dual blockade of CXCL12-CXCR4 and PD-1-PD-L1 pathways prolongs survival of ovarian tumor-bearing mice by prevention of immunosuppression in the tumor microenvironmentYang Zeng, Binghao Li, Yingying Liang, et al.
Cancer Management and Research|May 26, 2018
Prognostic factors for survival among patients with primary bone sarcomas of small bonesZhan Wang, Shu Li, Yong Li, et al.
Bioactive Materials|December 18, 2020
A trilogy antimicrobial strategy for multiple infections of orthopedic implants throughout their life cycleYikai Wang, Wangsiyuan Teng, Zengjie Zhang, et al.
Ebiomedicine|July 21, 2018
Survival Prediction in High-grade Osteosarcoma Using Radiomics of Diagnostic Computed TomographyYan Wu, Lei Xu, Pengfei Yang, et al.
Frontiers in Oncology|October 4, 2021
Clinical Features and Serological Markers Risk Model Predicts Overall Survival in Patients Undergoing Breast Cancer and Bone Metastasis SurgeriesHaochen Mou, Zhan Wang, Wenkan Zhang, et al.
Med (New York, N.Y.)|August 29, 2025
Anti-PD-1 antibody plus anlotinib vs. anlotinib alone in patients with refractory chondrosarcoma: A multicenter, non-randomized phase 2 FLAIL-C trialBinghao Li, Lu Xie, Junbo Liang, et al.
Nature Communications|October 23, 2022
Metabolic control of CD47 expression through LAT2-mediated amino acid uptake promotes tumor immune evasionZenan Wang, Binghao Li, Shan Li, et al.
NPJ Precision Oncology|September 11, 2021
Genomic characterization and outcome evaluation of kinome fusions in lung cancer revealed novel druggable fusionsBinghao Li, Hao Qu, Jing Zhang, et al.
Frontiers in Oncology|November 1, 2021
Predictive and Prognostic Biomarkers for Lung Cancer Bone Metastasis and Their Therapeutic ValueXupeng Chai, Eloy Yinwang, Zenan Wang, et al.
Frontiers in Immunology|March 11, 2024
Multiple influence of immune cells in the bone metastatic cancer microenvironment on tumorsShixin Chen, Jiangchu Lei, Haochen Mou, et al.
Pageof 7